Zim Laboratories Ltd. (IN:ZIMLAB)
:ZIMLAB
Want to see IN:ZIMLAB full AI Analyst Report?
Total Valuation
Zim Laboratories Ltd. has a market cap or net worth of ₹6.08B. The enterprise value is ₹6.30B.
Market Cap₹6.08B
Enterprise Value₹6.30B
Share Statistics
Zim Laboratories Ltd. has 53,549,038 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,549,038
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zim Laboratories Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.65%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.65%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee6.73M
Profits Per Employee105.00K
Employee Count556
Asset Turnover0.69
Inventory Turnover2.66
Valuation Ratios
The current PE Ratio of Zim Laboratories Ltd. is 96.4. Zim Laboratories Ltd.’s PEG ratio is -0.97.
PE Ratio96.4
PS Ratio0.79
PB Ratio1.00
Price to Fair Value1.00
Price to FCF-39.04
Price to Operating Cash Flow28.26
PEG Ratio-0.97
Income Statement
In the last 12 months, Zim Laboratories Ltd. had revenue of 3.74B and earned 58.38M in profits. Earnings per share was 1.19.
Revenue3.74B
Gross Profit1.25B
Operating Income100.32M
Pretax Income82.13M
Net Income58.38M
EBITDA300.10M
Earnings Per Share (EPS)1.19
Cash Flow
In the last 12 months, operating cash flow was 199.18M and capital expenditures -158.73M, giving a free cash flow of 40.45M billion.
Operating Cash Flow199.18M
Free Cash Flow40.45M
Free Cash Flow per Share0.76
Dividends & Yields
Zim Laboratories Ltd. pays an annual dividend of ₹0.167, resulting in a dividend yield of ―
Dividend Per Share₹0.167
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change6.47%
50-Day Moving Average91.56
200-Day Moving Average76.81
Relative Strength Index (RSI)69.76
Average Volume (3m)6.28K
Important Dates
Zim Laboratories Ltd. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 19, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Zim Laboratories Ltd. as a current ratio of 1.45, with Debt / Equity ratio of 42.45%
Current Ratio1.45
Quick Ratio0.96
Debt to Market Cap0.43
Net Debt to EBITDA2.74
Interest Coverage Ratio0.76
Taxes
In the past 12 months, Zim Laboratories Ltd. has paid 23.75M in taxes.
Income Tax23.75M
Effective Tax Rate0.29
Enterprise Valuation
Zim Laboratories Ltd. EV to EBITDA ratio is 12.59, with an EV/FCF ratio of -49.91.
EV to Sales1.01
EV to EBITDA12.59
EV to Free Cash Flow-49.91
EV to Operating Cash Flow10.27
Balance Sheet
Zim Laboratories Ltd. has ₹50.12M in cash and marketable securities with ₹1.23B in debt, giving a net cash position of -₹1.18B billion.
Cash & Marketable Securities₹50.12M
Total Debt₹1.23B
Net Cash-₹1.18B
Net Cash Per Share-₹22.02
Tangible Book Value Per Share₹51.78
Margins
Gross margin is 38.63%, with operating margin of 2.68%, and net profit margin of 1.56%.
Gross Margin38.63%
Operating Margin2.68%
Pretax Margin2.19%
Net Profit Margin1.56%
EBITDA Margin8.02%
EBIT Margin2.68%
Analyst Forecast
The average price target for Zim Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.22%
EPS Growth Forecast-52.32%